Bitcoin Treasury Corporation Announces Intention to Commence Normal Course Issuer Bid

Toronto, Ontario–(Newsfile Corp. – December 15, 2025) – Bitcoin Treasury Corporation (TSXV: BTCT) (OTCQB: BTCFF) (“Bitcoin Treasury” or the “Company“), a Canadian Bitcoin-native company building shareholder value in Bitcoin, today announced its intention to ‎initiate a Normal Course Issuer Bid (“NCIB“) through the facilities of the TSX Venture Exchange (“TSXV“) and/or alternative Canadian trading systems […]

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s mNEXSPIKE (COVID-19 Vaccine, mRNA)

mNEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine) mNEXSPIKE will be available in the European Union, subject to authorization by the European Commission CAMBRIDGE, MA / ACCESS Newswire / December 15, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European

PureHealth Research Launches Natural Vein Health Supplements for Youthful-Looking Legs

PureHealth Research today announced the launch of its new line of vein health supplements, offering a natural approach to supporting healthy circulation and promoting the appearance of youthful-looking legs. The collection represents the company's continued commitment to delivering science-backed wellness solutions. The new product line features carefully formulated supplements designed with plant-based ingredients that support

AppZen Launches AI Agent Studio, Disrupting Outsourcing with Digital Coworkers

CFOs are cutting operating costs by 50%, shifting from BPO to autonomous AI Agents AppZen, the leading agentic AI platform for finance teams, today announced the general availability of AI Agent Studio. First previewed in September, the AI Agent Studio allows finance teams to create and deploy AI Agents that act as digital coworkers, providing

Housecall Pro releases new report highlighting changing customer service standards in home contracting

Survey shows homeowners choose Pros for digital convenience, AI-assisted communication and clear pricing-proving that customer experience now wins the job Housecall Pro, a leading software platform for home service professionals, announces the release of its new report, “The New Home Service Standard: How Systems, Not Just Skills, Win the Customer.” The study highlights how customer

MAYFAIR ANNOUNCES SHARE CONSOLIDATION AND FILING OF NYSE AMERICAN LISTING APPLICATION

Mayfair Gold Corp. (“Mayfair”, “Mayfair Gold” or the “Company”) (TSXV: MFG) (OTCQX: MFGCF) is pleased to announce that the Company will consolidate its common shares at a ratio of two pre-consolidation shares to one post-consolidation share (the “Consolidation”), in support of its pursuit of a listing on the NYSE American Stock Exchange (the “NYSE American”).

EYLSIA NICOLAS TRIUMPHS WITH PATENT AWARD, CHART RECORDS, AND INSPIRING JOURNEY OF RESILIENCE

From Tennis Courts to Music Charts, Nicolas' Journey of Reinvention Inspires Across Generations Artist and innovator Eylsia Nicolas (stage name of Lisa Pamintuan) today announced the granting of U.S. Patent No. 12,507,007 in 3D sound technology, issued to Donald Spector and Lisa Pamintuan. The patent will be officially released on December 23, 2025, adding a

Sidoti Highlights Improved Financial Flexibility, Shelf Eligibility, Reduced Stock Overhang, and Focus on Operational Execution at TNL Mediagene

TNL Mediagene (Nasdaq: TNMG) (the “Company”), a Tokyo-based next-generation digital media and data group in Asia, today announced that Sidoti & Company, LLC (“Sidoti”) has published an update note highlighting improved financial flexibility and focus on operational execution at the Company. https://mma.prnewswire.com/media/2745246/TNL_primary_Logo.jpg “We view 2026 as a transition year for TNL Mediagene, with attention shifting

Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for imsidolimab, a novel IgG4 IL-36 receptor antagonist, to treat generalized pustular psoriasis (GPP). Imsidolimab inhibits IL-36 receptor signaling, addressing the deficiency in the endogenous IL-36RA regulator commonly seen in GPP

Doral Renewables Inks Power Purchase Agreement for the Lambs Draw Solar Project in Kansas

DoralRenewables has secured a Power Purchase Agreement (PPA) for its 270 MWac Lambs Draw Solar Project in Decatur County, Kansas. Under the agreement, a leading U.S. corporation will purchase 100% of the facility's energy output and associated Renewable Energy Credits. This milestone reinforces Doral Renewables' momentum in expanding its contracted energy portfolio across the United

Scroll to Top